News
FDA Panel to Consider COVID Vaccine Makeup for Next Season
The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using monovalent JN.1- or KP.2-lineage COVID-19 vaccine formulations -- the same as last year's -- with monovalent LP.8.1 lineage as a suitable alternative formulation.
The House Judiciary Committee revealed Thursday that Pfizer’s former Global Head of Vaccines Research and Development, Dr.
China continues to be a source of innovation as Pfizer strikes biggest pact yet; HHS provides more info on Trump’s Most Favored Nation executive order; FDA Commissioner Marty Makary and CBER director ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental The U.S. Food and Drug Administration (FDA) ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...
WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive ...
Novavax makes the nation’s only traditional protein-based coronavirus vaccine – and until now it had emergency authorization ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback